Role of Apolipoprotein A1 in PPAR Signaling Pathway for Nonalcoholic Fatty Liver Disease

Table 1

The prevalence of NAFLD decreased with the increase of APOA1 level.

APOA1 levels	Total patients	Patients with NAFLD	Prevalence rate	value	value
Q1	3300	1075	32.58%	292.109	<0.001
Q2	3165	893	28.21%
Q3	3156	680	21.55%
Q4	3202	499	15.58%